BACKGROUND: We report findings from a multi-method study investigating drug injectors' access to needles and syringes in three large Russian cities (Moscow, Volgograd, Barnaul). METHODS: We undertook 209 qualitative interviews among drug injectors, and supplemented these with baseline data from a community-recruited survey of 1473 drug injectors. FINDINGS: Almost all (93%; 1277) injectors used pharmacies as their main source of clean injecting equipment, and only 7% (105) reported ever having had contact with city syringe exchange projects. Good access to syringes has coincided with the expansion of private pharmacies. Key factors contributing to pharmacy access included: geographic proximity; low cost; and the restrictive policies of exchange instituted at local syringe exchanges. A fear of police interference surrounded the use of pharmacies and syringe exchanges, and fed a reluctance to carry used needles and syringes, which in turn acted as a disincentive to syringe exchange attendance. The perceived benefits of syringe exchanges over pharmacies included the additional health services on offer and the social support provided, but these benefits were over-shadowed by disadvantages. Multivariable analyses of survey data in two cities show no differences on account of risk behaviour among injectors sourcing equipment from pharmacies compared to syringe exchanges. CONCLUSIONS: HIV prevention coverage indicators need to include measures of pharmacy-based syringe distribution and not only measures of syringe exchange coverage. There is an urgent need to pilot pharmacy-based distribution and exchange projects in Russia as well as other forms of secondary syringe distribution. Alongside expanding the reach of dedicated syringe exchange projects, pharmacy-based syringe distribution, and exchange, may help improve coverage of cost effective HIV prevention measures targeting drug injectors.
BACKGROUND: We report findings from a multi-method study investigating drug injectors' access to needles and syringes in three large Russian cities (Moscow, Volgograd, Barnaul). METHODS: We undertook 209 qualitative interviews among drug injectors, and supplemented these with baseline data from a community-recruited survey of 1473 drug injectors. FINDINGS: Almost all (93%; 1277) injectors used pharmacies as their main source of clean injecting equipment, and only 7% (105) reported ever having had contact with city syringe exchange projects. Good access to syringes has coincided with the expansion of private pharmacies. Key factors contributing to pharmacy access included: geographic proximity; low cost; and the restrictive policies of exchange instituted at local syringe exchanges. A fear of police interference surrounded the use of pharmacies and syringe exchanges, and fed a reluctance to carry used needles and syringes, which in turn acted as a disincentive to syringe exchange attendance. The perceived benefits of syringe exchanges over pharmacies included the additional health services on offer and the social support provided, but these benefits were over-shadowed by disadvantages. Multivariable analyses of survey data in two cities show no differences on account of risk behaviour among injectors sourcing equipment from pharmacies compared to syringe exchanges. CONCLUSIONS: HIV prevention coverage indicators need to include measures of pharmacy-based syringe distribution and not only measures of syringe exchange coverage. There is an urgent need to pilot pharmacy-based distribution and exchange projects in Russia as well as other forms of secondary syringe distribution. Alongside expanding the reach of dedicated syringe exchange projects, pharmacy-based syringe distribution, and exchange, may help improve coverage of cost effective HIV prevention measures targeting drug injectors.
Authors: Javier A Cepeda; Marina V Vetrova; Alexandra I Lyubimova; Olga S Levina; Robert Heimer; Linda M Niccolai Journal: Int J Prison Health Date: 2015
Authors: Lucas Wiessing; Giedrius Likatavicius; Danica Klempová; Dagmar Hedrich; Anthony Nardone; Paul Griffiths Journal: Am J Public Health Date: 2009-04-16 Impact factor: 9.308
Authors: Kimberly C Brouwer; Remedios Lozada; John R Weeks; Carlos Magis-Rodríguez; Michelle Firestone; Steffanie A Strathdee Journal: Subst Use Misuse Date: 2011-12-02 Impact factor: 2.164
Authors: Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral Journal: Lancet HIV Date: 2017-05-14 Impact factor: 12.767
Authors: Kimberly C Brouwer; Melanie L Rusch; John R Weeks; Remedios Lozada; Alicia Vera; Carlos Magis-Rodríguez; Steffanie A Strathdee Journal: Ann Assoc Am Geogr Date: 2012
Authors: V Anna Gyarmathy; Nan Li; Karin E Tobin; Irving F Hoffman; Nikolai Sokolov; Julia Levchenko; Julia Batluk; Andrei A Kozlov; Andrei P Kozlov; Carl A Latkin Journal: AIDS Behav Date: 2009-02-13